This is utterly fantastic news! I am so excited and congratulations to the team. What an achievement!!!!
I have been curious for a while about the focus of Vaxinia on bile duct cancer though. Why the focus on such a rare form, when Prof. Fong and Ms. Chong have told us they suspect the drug will work across ALL forms of cancer? Is it because there are not many other trials in this space, therefore an easy target? Or is it strategic to fast track in a cohort with low numbers, as this will bring up the response rate percentages?
Not a criticism by any means - just curiosity.
Exciting day, great news.
Ann: FDA Fast Track Designation Granted for VAXINIA Trial Program, page-124
-
- There are more pages in this discussion • 289 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |